Rv2864c Cell division protein FtsI [Peptidoglycan synthetase] (EC 2.4.1.129)

Summary

Product Feature Type Start End Strand Length AA Length is TF
Rv2864c Cell division protein FtsI [Peptidoglycan synthetase] (EC 2.4.1.129) CDS 3175454 3177265 - 1 812 603 FALSE

Rv2864c (Cell division protein FtsI [Peptidoglycan synthetase] (EC 2.4.1.129)) is predicted to be co-regulated in modules bicluster_0474 with residual 0.57 and bicluster_0596 with residual 0.61.

This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 0.24 and 18,000.00 for bicluster_0474 and 0.00 and 0.03 for bicluster_0596 respectively.

These modules are enriched for following go terms: .

This gene is found to be for growth on cholesterol.

Mutant available?: Yes

Last update: 10/16/2017 - 14:41
BEI Mutant Available BEI Mutant ID BEI MT Number BEI Target ID Order from BEI
Yes NR-13463 MT2933 5
Product (LegacyBRC) Product (RefSeq)
POSSIBLE PENICILLIN-BINDING LIPOPROTEIN penicillin-binding lipoprotein
Operon # Operon
1873
PATRIC Locus Tag Enzyme Name PATRIC Pathways Transcriptomics

PATRIC

Peptidoglycan glycosyltransferase Peptidoglycan biosynthesis
Locus Tuberculist Genome View

Tuberculist

Quickview
Locus Tag KEGG Pathways

KEGG

not assigned to any KEGG Pathway.
BioCyc Gene Page Cellular Overview Map
Link to STRING STRING Network

STRING

GI Number Protein ID Blast Conserved Domains
15610001 NP_217380.1 Run
GO:0008955

peptidoglycan glycosyltransferase activity

peptidoglycan glycosyltransferase activity

Details: 
Catalysis of the reaction: [GlcNAc-(1,4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)](n)-diphosphoundecaprenol + GlcNAc-(1,4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol = [GlcNAc-(1,4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)](n+1)-diphosphoundecaprenol + undecaprenyl diphosphate.
GO Category: 
molecular_function
5
Total items in this category:  
No TFOE experiment results were found

Quantitative Proteomics Data

t-test p-value Cholesterol/Glycerol Ratio
0.860000 1.68

How essentiality calculations were done?

The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.

TRIP log2 fold abundance change

reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.

p-value Untreated:
p-value INH: